Clinical Outcomes of Patients with Histologic Variants of Urothelial Cancer Treated with Trimodality Bladder-sparing Therapy

Krasnow Ross E.; Drumm Michael; Roberts Hannah J.; Niemierko Andrzej; Wu Chin-Lee; Wu Shulin; Zhang Jing; Heney Niall M.; Wszolek Matthew F.; Blute Michael L.; Feldman Adam S.; Lee Richard J.; Zietman Anthony L.; Shipley William U.; Efstathiou Jason A.

首页> 外文期刊>European urology >Clinical Outcomes of Patients with Histologic Variants of Urothelial Cancer Treated with Trimodality Bladder-sparing Therapy

【24h】

Clinical Outcomes of Patients with Histologic Variants of Urothelial Cancer Treated with Trimodality Bladder-sparing Therapy

机译：三极性膀胱稀释治疗治疗尿路上癌组织学变体患者的临床结果

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background: Trimodality bladder-sparing therapy (TMT) is an acceptable treatment for selected patients with muscle-invasive urothelial cancer. Outcomes of TMT in histologic variants remains largely unknown.

机译：背景：Trimodality Bladder-Sparing疗法（TMT）是针对肌肉侵袭性尿路上皮癌的选定患者的可接受的治疗方法。组织学变体中TMT的结果仍然很大程度上是未知的。

著录项

来源
《European urology》 |2017年第1期|共7页
作者
Krasnow Ross E.; Drumm Michael; Roberts Hannah J.; Niemierko Andrzej; Wu Chin-Lee; Wu Shulin; Zhang Jing; Heney Niall M.; Wszolek Matthew F.; Blute Michael L.; Feldman Adam S.; Lee Richard J.; Zietman Anthony L.; Shipley William U.; Efstathiou Jason A.;
展开▼
作者单位

Harvard Med Sch Massachusetts Gen Hosp Dept Urol Boston MA USA;

Harvard Med Sch Massachusetts Gen Hosp Dept Radiat Oncol Boston MA USA;

Harvard Med Sch Massachusetts Gen Hosp Dept Radiat Oncol Boston MA USA;

Harvard Med Sch Massachusetts Gen Hosp Dept Radiat Oncol Boston MA USA;

Harvard Med Sch Massachusetts Gen Hosp Dept Pathol Boston MA USA;

Harvard Med Sch Massachusetts Gen Hosp Dept Pathol Boston MA USA;

Harvard Med Sch Massachusetts Gen Hosp Dept Pathol Boston MA USA;

Harvard Med Sch Massachusetts Gen Hosp Dept Urol Boston MA USA;

Harvard Med Sch Massachusetts Gen Hosp Dept Urol Boston MA USA;

Harvard Med Sch Massachusetts Gen Hosp Dept Urol Boston MA USA;

Harvard Med Sch Massachusetts Gen Hosp Dept Urol Boston MA USA;

Harvard Med Sch Massachusetts Gen Hosp Dept Med Div Hematol &

Oncol Boston MA USA;

Harvard Med Sch Massachusetts Gen Hosp Dept Radiat Oncol Boston MA USA;

Harvard Med Sch Massachusetts Gen Hosp Dept Radiat Oncol Boston MA USA;

Harvard Med Sch Massachusetts Gen Hosp Dept Radiat Oncol Boston MA USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类泌尿科学（泌尿生殖系疾病）;
关键词
Bladder cancer; Chemotherapy; Combined-modality therapy; Trimodality therapy; Cystectomy; Radiation therapy; Histology; Outcomes;

机译：膀胱癌;化疗;组合式疗法;三极性疗法;膀胱切除术;放射治疗;组织学;结果;

相似文献

外文文献
中文文献
专利

1. Clinical Outcomes of Patients with Histologic Variants of Urothelial Cancer Treated with Trimodality Bladder-sparing Therapy [J] . Krasnow Ross E., Drumm Michael, Roberts Hannah J., European urology . 2017,第1期

机译：三极性膀胱稀释治疗治疗尿路上癌组织学变体患者的临床结果
2. Re: Outcome of Patients with Micropapillary Urothelial Carcinoma following Radical Cystectomy: ERBB2 (HER2) Amplification Identifies Patients with Poor Outcome Editorial Comment - Re: Significance of ERBB2 Overexpression in Therapeutic Resistance and Cancer-Specific Survival in Muscle-Invasive Bladder Cancer Patients Treated with Chemoradiation-Based Selective Bladder-Sparing Approach Editorial Comment [J] . Chang Sam S. The Journal of Urology . 2015,第3期

机译：Re：患有微量膀胱切除术后的患者的结果：ERBB2（HER2）扩增鉴定了较差的结果患者编辑评论 - RE：肌肉侵袭性膀胱癌患者治疗性抗性和癌症特异性存活中的ERBB2过表达的意义基于选择性的膀胱保留方法编辑评论
3. Re: Outcome of Patients with Micropapillary Urothelial Carcinoma following Radical Cystectomy: ERBB2 (HER2) Amplification Identifies Patients with Poor Outcome Editorial Comment - Re: Significance of ERBB2 Overexpression in Therapeutic Resistance and Cancer-Specific Survival in Muscle-Invasive Bladder Cancer Patients Treated with Chemoradiation-Based Selective Bladder-Sparing Approach Editorial Comment [J] . Chang Sam S. The Journal of Urology . 2015,第3期

机译：回复：根治性膀胱切除术后微乳头状尿路上皮癌患者的结果：ERBB2（HER2）扩增可确定结果较差的患者基础的选择性膀胱保留方法社论评论
4. Clinical Outcome of Breast and Ovarian Cancer Patients Treated after High-Dose Chemotherapy and Autologous Stem Cell Rescue with Theratope (STn-KLH) Cancer Vaccine: Theratope (STn-KLH) Cancer Vaccine following Autologous Transplant [C] . Leona A. Holmberg, Katherine A. Guthrie, Brenda M. Sandmaier Chemical glycobiology . -1

机译：大剂量化学疗法和自体干细胞拯救治疗的Theratope（STn-KLH）癌症疫苗治疗的乳腺癌和卵巢癌患者的临床结果：自体移植后的Theratope（STn-KLH）癌症疫苗
5. Clinical and Economic Outcomes for Gastric Cancer Patients Treated with Gastrectomy at Centres with and without Cancer Surgery Designation in Ontario [D] . Jeong, Yunni . 2019

机译：安大略省患有癌症手术指定胃癌治疗胃癌患者的胃癌患者的临床和经济结果
6. Outcomes of trimodality bladder-sparing therapy for muscle-invasive bladder cancer [O] . Eric K. Nguyen, Hang Yu, Gregory Pond, 2020

机译：肌浸润性膀胱癌的三峰保留膀胱疗法的结果
7. Clinical Outcomes of Combined Modality Bladder-Sparing Therapy for Patients With Histologic Variants of Bladder Cancer [O] . H.J. Roberts, R.E. Krasnow, M.R. Drumm, 2016

机译：膀胱癌组织学变体患者组合式膀胱缺陷治疗临床结果

Clinical Outcomes of Patients with Histologic Variants of Urothelial Cancer Treated with Trimodality Bladder-sparing Therapy

摘要

著录项

相似文献

相关主题

期刊订阅